LM 3339

Drug Profile

LM 3339

Latest Information Update: 06 Jun 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck Sante
  • Class Antiasthmatics; Muscle relaxants; Small molecules
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 06 Jun 2001 Discontinued-Preclinical for Asthma in France (Inhalation)
  • 31 Aug 1998 No-Development-Reported for Asthma in France (Inhalation)
  • 04 Oct 1996 Preclinical development for Asthma in France (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top